The global nasal packing devices market size was valued at USD 173.97 million in 2021. It is projected to reach USD 274.55 million by 2030, growing at a CAGR of 5.2% during the forecast period (2022–2030).
Temporary or permanent nasal packing is required if the otorhinolaryngologist is unable to determine the source of the bleeding and there is no access to specialized equipment or endoscopic management expertise or if the patient cannot tolerate extensive bedside nasal manipulation. In a population-based epidemiologic study of U.S. emergency departments, risk factors linked to the initial use of nasal packing for epistaxis include:
Epistaxis is one of the most prevalent clinical diseases that result in bleeding from the nostrils. The rising epistaxis is the crucial factor driving the nasal packing devices market.
| Report Metric | Details |
|---|---|
| Base Year | 2021 |
| Study Period | 2020-2030 |
| Forecast Period | 2023-2031 |
| CAGR | 5.2% |
| Market Size | USD 274.55 million by 2030 |
| Fastest Growing Market | Asia Pacific |
| Largest Market | North America |
| Report Coverage | Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends |
| Geographies Covered |
|
Intranasal devices positioned to apply constant local pressure on the nasal septum are known as nasal packing devices and can be placed within the nose. Epistaxis is the result of a combination of several factors that either cause damage to the mucosal lining of the nose, affect the blood vessel walls, or impair the blood's ability to clot. After cauterization has been tried and found to be ineffective, nasal packing is used to treat epistaxis. The incidence of nosebleeds is highest among children between the ages of 2 and 10, adults, and elders between the ages of 50 and 80, according to a nosebleed study conducted in the United States.
The increasing prevalence of epistaxis is a significant factor propelling growth in the nasal packing devices market. Epistaxis, one of the most prevalent clinical diseases, can result in bleeding from the nostrils due to hypertension. Nosebleeds are caused by increased blood circulation caused by the circulatory system expansion during pregnancy. As a result, the market's growth is driven by an increase in the number of pregnant women suffering from hypertension. In addition, the growing incidence of nasal malignancies is driving the growth of this market.
Nasal packing device sales are hindered by its complications, such as those related to mucosal lacerations, which can exacerbate bleeding, lead to viral complications, and toxic shock syndrome (TSS). The industry's growth is anticipated to be constrained by the high costs associated with ENT surgical procedures. Additionally, a lack of qualified specialists is anticipated in the ear and nasal packing market, which is a source of competition.
Some of the market's most cutting-edge traits and trends are currently propelling its overall expansion. The most critical industry participants and leading manufacturers invest heavily in research and development. The market's growth is frequently accelerated by crucial factors, including niche market penetrations, vendor landscapes, marketing slants, licensing tactics, relative market share, pinpoint analysis, visual analytics, etc. Market leaders are also constantly searching for cutting-edge technology that could significantly accelerate their future commercial growth. The market is propelled forward by an increasing number of product launches and a persistent focus on technological advancements.
The global nasal packing devices market is segmented into four regions, namely North America, Europe, Asia-Pacific, and LAMEA.
North America is the most significant shareholder in the global nasal packing devices market due to the increased utilization of nasal packing devices to treat an ever-increasing number of epistaxis patients and the growing number of market competitors in the region. An increase in COVID-19 cases contributes to the growth in demand for nasal packing devices. Asia-Pacific will experience a favorable growth rate in the market during the forecast period. This development may be attributable to several factors, including an increase in the number of manufacturers of nasal packing devices, a high level of unmet demands, a flourishing economy, and an overall improvement in healthcare infrastructure, particularly in developing nations such as China and India
The global nasal packing devices market is segmented by product and type.
Based on product, the market is divided into injectable, gel, spray, and dressings.
The spray category dominates the global nasal packing devices market. This new treatment involves spraying cotton balls directly into the nasal cavity to pack the nasal passages. There are two sorts of nasal sprays: saline and decongestant. Gel packaging is anticipated to experience the highest growth rate during the forecast period. The market is expected to grow because of recent developments and the effectiveness of gel production, which is expected to help with hemostasis and high patient comfort. Gel and dressings are the most prevalent and effective treatments for nosebleeds. MeroGel by Medtronic is one of the market's most popular nasal dressings.
Based on type, the market is divided into bio-resorbable and non-absorbable.
The non-absorbable sector is dominant in the global nasal packing devices market. In addition to being more well-known and preferred by doctors, non-absorbable nasal packing devices are significantly less expensive than bioresorbable nasal packing devices. It is anticipated that the bioresorbable sector will experience the highest growth rate during the forecast period due to the rapid technological advancements and the rising number of new brands being introduced to the market. Patients benefit greatly from bioresorbable nasal packing devices because the procedure causes less discomfort and offers more significant benefits.
